Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosa

scientific article published on December 2008

Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosa is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0035-9203(08)70033-6
P932PMC publication ID2709407
P698PubMed publication ID19121678

P2093author name stringHerbert P Schweizer
Richard A Moore
Donald T Moir
Donald E Woods
Ming Di
P2860cites workA comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.Q39356268
Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance.Q39472156
Transcriptome analysis of the response of Pseudomonas aeruginosa to hydrogen peroxideQ40377337
Peptide inhibitors of the essential cell division protein FtsA.Q40435544
Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposonsQ40687515
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosaQ41781241
Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibioticsQ41895644
A high-throughput, homogeneous, bioluminescent assay for Pseudomonas aeruginosa gyrase inhibitors and other DNA-damaging agentsQ43114724
Gene expression in Pseudomonas aeruginosa biofilmsQ43777487
Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strainsQ44786412
Chemical evolution of the fluoroquinolone antimicrobial agentsQ45743334
Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosaQ46397999
Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductaseQ47986775
Antimicrobial resistance in Burkholderia pseudomallei.Q54062578
Analysis of Pseudomonas gene products using lacIq/Ptrp-lac plasmids and transposons that confer conditional phenotypesQ57936335
The N-terminus promotes oligomerization of the Escherichia coli initiator protein DnaAQ73129161
Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strainsQ73301855
Transcriptome analysis of the Pseudomonas aeruginosa response to ironQ79088334
Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655Q22065459
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogenQ22122393
From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathwaysQ24539226
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomalleiQ24550664
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomalleiQ24564168
An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutantsQ24815663
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysQ28145712
Halving of mortality of severe melioidosis by ceftazidimeQ28257666
Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathwayQ28492538
Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genesQ28492731
GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genesQ28492754
Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacinQ29346807
Drugs for bad bugs: confronting the challenges of antibacterial discoveryQ29547723
Comprehensive transposon mutant library of Pseudomonas aeruginosaQ29614861
Acetylornithinase of Escherichia coli: partial purification and some propertiesQ29615297
Database resources of the National Center for Biotechnology Information: 2002 updateQ30782351
Panel of Bacillus subtilis reporter strains indicative of various modes of actionQ31081404
Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosisQ31876656
BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomalleiQ33200347
Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutantsQ33803840
Pathogenesis of and immunity to melioidosisQ33837734
Microarray analysis and functional characterization of the nitrosative stress response in nonmucoid and mucoid Pseudomonas aeruginosa.Q34350755
Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia malleiQ34758894
Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production.Q37119379
Transcriptome analysis of quorum-sensing regulation and virulence factor expression in Pseudomonas aeruginosaQ38333629
The epidemiology of melioidosis in Australia and Papua New GuineaQ38958168
P921main subjectPseudomonas aeruginosaQ31856
Burkholderia pseudomalleiQ140475
P304page(s)S152-62
P577publication date2008-12-01
P1433published inTransactions of the Royal Society of Tropical Medicine and HygieneQ15766916
P1476titleCellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosa
P478volume102 Suppl 1

Reverse relations

cites work (P2860)
Q35816288Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen
Q33908076Development and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei
Q33533545Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion
Q35960740Discovery of bacterial fatty acid synthase type II inhibitors using a novel cellular bioluminescent reporter assay
Q33622815Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion system
Q28493113The Pseudomonas aeruginosa periplasmic protease CtpA can affect systems that impact its ability to mount both acute and chronic infections

Search more.